No Data
No Data
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
Earnings Week Ahead: MSFT, AAPL, META, AMZN, QCOM, PFE, MA, V, PYPL, ROKU, MCD, SBUX, KO, and More
BofA Securities Maintains Regeneron Pharmaceuticals(REGN.US) With Sell Rating, Maintains Target Price $547
Baird Maintains Regeneron Pharmaceuticals(REGN.US) With Hold Rating, Cuts Target Price to $652
Regeneron Pharma Is Maintained at Neutral by Baird
Regeneron Pharma Price Target Cut to $652.00/Share From $759.00 by Baird